Total | T1DM | T2DM | p | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Total Number of People With Diabetes | 100,650 | 100% | 11,826 | 11.7% | 88,824 | 88.3% | – |
Subgroup of Existing Insulin Users During the Pre-period | 79,053 | 78.5% | 10,975 | 92.8% | 68,078 | 76.6% | < 0.0001 |
Characteristics | |||||||
Age (n, %) | < 0.0001 | ||||||
18–40 | 8068 | 8.0% | 4843 | 41.0% | 3225 | 3.6% | |
41–60 | 32,960 | 32.7% | 4713 | 39.9% | 28,247 | 31.8% | |
> 60 | 59,622 | 59.2% | 2270 | 19.2% | 57,352 | 64.6% | |
Age (mean, SD) | 62.18 | 14.24 | 45.26 | 16.27 | 64.43 | 12.30 | < 0.0001 |
Gender (n, %) | 0.0003 | ||||||
Male | 51,983 | 51.6% | 6290 | 53.2% | 45,693 | 51.4% | |
Female | 48,651 | 48.3% | 5532 | 46.8% | 43,119 | 48.5% | |
Missing | 16 | 0.0% | 4 | 0.0% | 12 | 0.0% | |
Business Line (n, %) | < 0.0001 | ||||||
Commercial | 43,573 | 43.3% | 9566 | 80.9% | 34,007 | 38.3% | |
Medicare advantage | 57,077 | 56.7% | 2260 | 19.1% | 54,817 | 61.7% | |
Household Income, in US Dollars | |||||||
n (%) | 100,196 | 99.5% | 11,801 | 99.8% | 88,395 | 99.5% | |
Median, Q1 - Q3 | $54,143 | $43,184 - $69,606 | $63,304 | $49,195 - $81,547 | $53,299 | $42,675 - $68,059 | < 0.0001 |
Medical Claims | |||||||
Number of Medical Claims (median, Q1 - Q3) | 7.00 | 4.00–15.00 | 5.00 | 3.00–10.00 | 8.00 | 4.00–15.00 | < 0.0001 |
Proportion of Medical Claims 2,3 That are Diabetes Related (mean, SD) | 0.54 | 0.31 | 0.60 | 0.33 | 0.52 | 0.30 | < 0.0001 |
Number of HbA1c Tests | |||||||
One or More Tests Performed (n, %) | 60,668 | 60.3% | 7137 | 60.4% | 53,531 | 60.3% | 0.86 |
Mean, SD | 0.91 | 0.93 | 0.89 | 0.88 | 0.91 | 0.94 | 0.0007 |
Latest HbA1c Value | |||||||
n (%) | 31,410 | 31.2% | 3417 | 28.9% | 27,993 | 31.5% | |
Mean, SD | 8.84 | 1.94 | 8.38 | 1.64 | 8.89 | 1.96 | < 0.0001 |
Insulin Administration and Diabetes Technology (n, %) | < 0.0001 | ||||||
CGM with pump | 1974 | 2.0% | 1734 | 14.7% | 240 | 0.3% | |
CGM with pen | 800 | 0.8% | 342 | 2.9% | 458 | 0.5% | |
CGM with vial | 277 | 0.3% | 200 | 1.7% | 77 | 0.1% | |
BGM with pump | 2098 | 2.1% | 1516 | 12.8% | 582 | 0.7% | |
BGM with pen | 23,078 | 22.9% | 2032 | 17.2% | 21,046 | 23.7% | |
BGM with vial | 8380 | 8.3% | 1078 | 9.1% | 7302 | 8.2% | |
No CGM or BGM/pump | 2410 | 2.4% | 1236 | 10.5% | 1174 | 1.3% | |
No CGM or BGM/pen | 44,108 | 43.8% | 2208 | 18.7% | 41,900 | 47.2% | |
No CGM or BGM/vial | 17,525 | 17.4% | 1480 | 12.5% | 16,045 | 18.1% | |
Type of Insulin (n, %) | < 0.0001 | ||||||
N | 77,912 | 77.4% | 10,524 | 89.0% | 67,388 | 75.9% | |
Basal only | 31,917 | 41.0% | 893 | 8.5% | 31,024 | 46.0% | |
Bolus only | 8949 | 11.5% | 4742 | 45.1% | 4207 | 6.2% | |
Both | 37,046 | 47.5% | 4889 | 46.5% | 32,157 | 47.7% | |
Months on Insulin (mean, SD) | 3.99 | 3.48 | 4.81 | 3.26 | 3.89 | 3.49 | < 0.0001 |
Clinical Characteristics | |||||||
Number of Concordant Comorbidities (mean, SD) | 4.20 | 2.57 | 0.87 | 1.17 | 4.64 | 2.38 | < 0.0001 |
Number of Discordant Comorbidities (mean, SD) | 1.07 | 1.11 | 1.83 | 1.62 | 0.97 | 0.98 | < 0.0001 |
Charlson Comorbidity Index (CCI) (mean, SD) | 1.86 | 1.60 | 1.40 | 1.21 | 1.92 | 1.63 | < 0.0001 |
Diabetes Complication Severity Index (DCSI) (mean, SD) | 1.07 | 1.47 | 0.58 | 1.09 | 1.13 | 1.50 | < 0.0001 |